Application Nr Approved Date Route Status External Links
ANDA203574 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mesalamine Delayed-Release Tablets Are Indicated For The Induction Of Remission In Patients With Active, Mild To Moderate Ulcerative Colitis And For The Maintenance Of Remission Of Ulcerative Colitis. Mesalamine Delayed-Release Tablets Are A Locally Acting 5-Aminosalicylic Acid (5-Asa) Indicated For The Induction Of Remission In Adults With Active, Mild To Moderate Ulcerative Colitis And For The Maintenance Of Remission Of Ulcerative Colitis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesalamine MESALAMINE ZINC1688

Comments